Literature DB >> 22248786

Testicular adrenal rest tumours in boys with congenital adrenal hyperplasia: case report and literature review.

Elżbieta Budzyńska1, Iwona Beń-Skowronek.   

Abstract

Nodular testicular lesions derived from adrenal tissue (testicular adrenal rest tumours - TART) in boys and men with congenital adrenal hyperplasia (CAH) lead to testicular structure damage, spermatogenesis disorders, and infertility. Hyperplasia of the ectopic adrenal tissue in testes is associated with high levels of the adrenocorticotropic hormone (ACTH) in blood serum. The development of non-invasive methods of diagnostic imaging allows detection of testicular lesions in adolescents and children. The basic method for TART detection is imaging with ultrasonography (USG) being the most widely available method. Since these mild testicular lesions can cause impaired fertility, periodic palpation and testicular ultrasonography should be performed in patients with CAH in order to prevent infertility.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22248786

Source DB:  PubMed          Journal:  Pediatr Endocrinol Diabetes Metab        ISSN: 2083-8441


  4 in total

1.  Late diagnosis of classic congenital adrenal hyperplasia: long-term consequences during adulthood.

Authors:  Mariana Aveiro-Lavrador; Adriana De Sousa Lages; Luísa Barros; Isabel Paiva
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-05-01

2.  Testicular adrenal rest "tumor" or Leydig cell tumor? A report of a challenging case with literature review.

Authors:  Hiba Hassan Ali; Alaa Samkari; Haitham Arabi
Journal:  Avicenna J Med       Date:  2013-01

3.  Testicular adrenal rest tumor mimicking leydig cell tumor in a patient with congenital adrenal hyperplasia.

Authors:  Esra Karakuş; Müjdem Nur Azılı; Tuğrul Tiryaki
Journal:  APSP J Case Rep       Date:  2014-04-01

4.  A Klinefelter boy with congenital adrenal hyperplasia: too much or too little androgens?

Authors:  Giada Zanella; Gianluca Tornese; Elisabetta Mascheroni; Elena Faleschini; Alessandro Ventura; Egidio Barbi
Journal:  Ital J Pediatr       Date:  2018-04-03       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.